Status | Study |
RECRUITING |
Study Name: Ph4 PSG Combined JZP258-407 Condition: Idiopathic Hypersomnia Date: 2023-05-16 Interventions: Initiate dosage per XYWAV label and titrate to variable dosage. |
RECRUITING |
Study Name: Low Sodium Oxybate in Patients With Idiopathic Hypersomnia Condition: Idiopathic Hypersomnia Date: 2023-04-19 Interventions: Titrated according to standard of care and continued on stable dose for 3 months |
Completed |
Study Name: Cardiovascular Variability and Heart Rate Arousal Response in Idiopathic Hypersomnia Condition: Narcolepsy Cataplexy Date: 2016-09-22 Interventions: Device: Polysomnography The polysomnography, for both groups, was performed accordance with standard pra |
Recruiting |
Study Name: A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2 Condition: Idiopathic Hypersomnia Narcolepsy Without Cataplexy Date: 2015-07-23 Interventions: Drug: BTD-001 Drug: Placebo |
Recruiting |
Study Name: Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford Condition: Rare Disorders Undiagnosed Disorders Disorders of Unknown Date: 2013-02-13 |
Recruiting |
Study Name: Neurophysiologic Correlates of Hypersomnia Condition: Major Depressive Disorder Primary Hypersomnia Date: 2012-10-24 Interventions: Other: Acoustical slow wave induction Brief tones (50 millisecond duration) at a frequency of 0.8 and 2 |
Completed |
Study Name: Flumazenil for the Treatment of Primary Hypersomnia Condition: Hypersomnia Primary Hypersomnia Date: 2010-08-09 Interventions: Drug: Flumazenil Sublingual flumazenil |
Completed |
Study Name: Clarithromycin for the Treatment of Hypersomnia Condition: Hypersomnia Idiopathic Hypersomnia Date: 2010-06-15 Interventions: Drug: Clarithromycin followed by placebo |